Of special interest to Dr. McNeil are patients who have immune deficiencies or angioedema. He has traveled widely to speak about angioedema and meet patients with all types of the condition.

Dr. McNeil is an Associate Professor of Clinical Medicine at The Ohio State University and does Allergy Training for the OSU ENT Residency Program. In addition to being on the medical teaching staff of Mt. Carmel, Doctors and Riverside Methodist Hospitals, Dr. McNeil is also on the consulting staff of Grant Hospital in Columbus and Bethesda Hospital in Zanesville, Ohio. A member of the American College of Physicians, Dr. McNeil is board certified in allergy, immunology and internal medicine. He has published numerous articles related to asthma, allergy and immunology.

Dr. McNeil is president, founder, and principal investigator at Optimed Research, and has over 20 years of research experience. Certified as a clinical investigator since June, 2005, Dr. McNeil has conducted research studies in the following areas: Pneumonia, sinusitis, bronchitis, CVID, allergic rhinitis, rheumatoid arthritis, hyperlipidemia, hypercholesterolemia, osteoarthritis pain, hereditary angioedema, diabetes, and asthma.

Dr. McNeil founded Optimed Infusion LLC. in 1999 and is the Medical Director. He provides oversight of the infusion clinic, which administers IVIg treatments to patients with immunodeficiency in the Columbus, Ohio area.

Dr. McNeil sees patients at Midwest Allergy’s Worthington, Chillicothe, Zanesville and Newark offices.

Dr. Gordon Myers received his Bachelor of Arts degree from the University of Richmond. He earned his Doctor of Medicine degree from St. George’s University School of Medicine and completed his residency the University of Tennessee at Chattanooga in Pediatrics. During his residency, he received the Intern of the Year award. After that, he entered a combined adult and pediatric fellowship in allergy and immunology at Louisiana State University in New Orleans. During his time there, he focused on his passions of immunodeficiency and food allergy.

Dr. Gordon is board certified in allergy and immunology and in pediatrics.

After completing his education, Dr. Gordon, known Dr. G, returned home to join Cincinnati Allergy & Asthma Center as part of the third generation of allergists. Since his return, he has provided oral immunotherapy (OIT) to his peanut allergic patients and treats patients with recurrent infections. As an allergy and asthma sufferer himself, he remains committed to the practice of evidence-based medicine with an emphasis on patient-centered care and shared decision making.

Amber Patterson, MD is a world-renowned allergy/immunology expert and the US ambassador for intralymphatic allergen immunotherapy (ILIT™). Before founding Auni Allergy®, she developed the first US clinical trial for ILIT™ (first in the world for pediatrics) as faculty at the Ohio State University Wexner Medical Center and Nationwide Children’s hospital where she founded the Center for Immunotherapy. She holds several patents on novel allergy drug and testing devices.

Dr. Patterson leads as chair of the American Academy of Allergy Asthma and Immunology (AAAAI) immunotherapy and diagnostics committee. She is a board-certified allergist/immunologist, fellow of both the AAAAI and the American College of Allergy Asthma and Immunology, as well as clinical assistant professor in the University of Toledo College of Medicine. Believing in the powerful connection between mind and body, she also volunteers on her local hospital foundation (Blanchard Valley) and community recreation center (YMCA) boards of directors, aiming to co-create positive community resources for physical, mental, and spiritual growth. As a wife and mother of four, Amber’s hobbies include investing in her children, relaxing at the lake with her husband, and traveling the world.

Her company Auni Allergy® is a family-owned allergy medical service chain with 9 practices in 4 states and a research and development division headquartered in Findlay, OH. The company was founded in 2020 with a dream of providing people with allergies and immune dysfunction access to convenient treatment options that are safe and effective. Dr. Amber Patterson’s early work with ILIT™ was the scientific foundation for the company. ILIT™ is an ultrasound-guided injection for rapid aeroallergen immunotherapy, reducing allergy treatment time from 100s of shots over 5 years to 3 injections over 8 weeks. Rooted in science, driven by patient needs, Auni Allergy® is pioneering the concept of prioritizing allergy/immunology treatments to fit patients’ lifestyles.

Licensing innovative treatment methods to independent physicians and institutions is key to bringing access to ILIT™ nationwide. Together we are shifting the paradigm of how allergists treat allergies. In 2022 the licensing and clinical service divisions began doing business as Auni Allergy®, and the first license was granted to Shepherd Allergy in West Virginia. 2023 brought the organization of our licensed medical practices into a healthcare learning network, the Auni® ILIT™ Learning Network and opening of full-service Auni Allergy®-branded allergy/immunology clinics in Northwest Ohio (Findlay, Bowling Green and plans for 2024 Perrysburg). In 2024 our Auni® Research and development division was selected as a clinical site for phase 2 and 3 pharmaceutical research trials, and we continue development of patented food allergy and venom treatments which will revolutionize the future for families living with food & venom allergies.

Dr. Patterson is a proud member of CIIC, a place where physician entrepreneurs collaborate and thrive for the benefit of their patients.